← All indications
Fever
An abnormal elevation of body temperature, usually as a result of a pathologic process.
Subtype terms (3)
More specific conditions that are subtypes of Fever in the MeSH hierarchy.
- Drug Fever
- Fever of Unknown Origin
3 drugs (1 approved, 2 experimental)
- Sweating Sickness
Drugs by status
Approved for this indication (15)
Phase 4 trials (30)
- levofloxacin
- diclofenac
- procaine benzylpenicillin
- tobramycin
- black cohosh
- ceftazidime
- clavulanate
- doxycycline
- ibuprofen
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- amoxicillin
- metamizole
- vitamin c
- palivizumab
- piperacillin
- pneumococcal 13-valent conjugate vaccine
- vancomycin
- itraconazole
- ciprofloxacin
- 10-valent Pneumococcal Conjugate Vaccine
- azithromycin
- meropenem
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- rabies vaccine adsorbed
- ertapenem
- ofloxacin
- anakinra
- tazobactam
- mrna-1273
- bnt162b2
Phase 3 trials (36)
- iron
- canakinumab
- ceftobiprole
- dantrolene
- doxorubicin
- fluorouracil
- Filgrastim
- artesunate
- leucovorin
- loxoprofen
- pelubiprofen
- peramivir
- pomegranate
- rotavirus vaccine, live, oral, pentavalent
- cyclophosphamide
- sulfamethoxazole
- bevacizumab
- tivantinib
- dapsone
- endotoxin
- amphotericin b
- bifidobacterium longum
- inactivated influenza vaccine
- amodiaquine
- chlorproguanil
- cefepime
- sargramostim
- sodium chloride
- dexibuprofen
- lumefantrine
- +6 more
Phase 2 trials (24)
Phase 1 trials (7)
Other trials (29)
- spirulina
- acetylcysteine
- artemisinin
- clonazepam
- methylphenidate
- e. coli endotoxin
- fufangshuanghua
- glycopyrronium
- ritonavir
- ketorolac
- lidocaine
- procalcitonin
- sitagliptin
- desflurane
- diazepam
- salmonella enterica serovar paratyphi a (strain nvgh308)
- sulfadoxine
- chloroquine
- moxifloxacin
- pyrimethamine
- phenyltoxamine
- salicin
- amikacin
- cloxacillin
- imipenem
- remifentanil
- cinnamyl alcohol
- wheat
- lactobacillus delbrueckii
Organizations
Organization Involved with Phase 4 Indications (62)
- Merck
- Pfizer
- Sanofi
- Wyeth
- Cumberland Pharmaceuticals
- GlaxoSmithKline
- Institut Pasteur
- Mantecorp Industria Quimica e Farmaceutica Ltd.
- Unipharm, Inc.
- Epicentre
- ZonMw: The Netherlands Organisation for Health Research and Development
- Medical Research Council
- Aarhus University
- Albert Schweitzer Hospital
- Duke University
- International Vaccine Institute
- Kaiser Permanente
- Michigan State University
- Pamukkale University
- Radboud University
- Seoul National University
- Singapore General Hospital
- Tanta University
- University of Oulu
- University of Patras
- University of Athens
- Columbia University
- General Hospital of Chalkida
- Prince of Songkla University
- Tel Aviv University
- +32 more
Organization Involved with Phase 3 Indications (51)
- Basilea Pharmaceutica
- Eli Lilly
- Sanofi-Aventis
- Novartis
- Bayer
- Mallinckrodt
- Medical Enterprises Europe B.V.
- French National Agency for Research on AIDS and Viral Hepatitis
- Israel Defense Force
- National Cancer Institute (NCI)
- Maastricht University
- Cancer Research Campaign
- University of London
- Inje University
- Katholieke Universiteit Leuven
- Nagoya University
- New York Medical College
- Northwestern University
- Stanford University
- Swiss Pediatric Oncology Group
- University of Groningen
- University of Lausanne
- University of Pisa
- University of Bern
- University of Bonn
- University of Zurich
- Group Health Cooperative
- Peking University
- University of California, Los Angeles
- University of Basel
- +21 more
Organization Involved with Phase 2 Indications (61)
- DuPont
- Avant Immunotherapeutics
- Bausch Health Companies
- Forest Laboratories
- Novo Nordisk
- ASIT Biotech S.A.
- Allergan
- Celsion
- Ichor Medical Systems Incorporated
- Implicit Bioscience
- MacroGenics
- S&D Pharma SK s.r.o.
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Polytechnic Institute, Mexico
- Slovak Academy of Sciences
- United States Army
- University of Pittsburgh
- Canadian Critical Care Trials Group
- Cornell University
- Harvard University
- Oregon Health and Science University
- Richmond University Medical Center
- Shin Kong Wu Ho-Su Memorial Hospital
- University of Kansas
- University of Maryland
- University of Miami
- University of Rochester
- University of Toronto
- Wuhan University
- +31 more
Organization Involved with Phase 1 Indications (20)
- Inviragen
- BioCryst
- Enzon
- AstraZeneca
- Hamad Medical Corporation
- Tubitak
- Universidad de Antioquia
- Thomas Jefferson University
- Utrecht University
- University of Minnesota
- International Center for Diarrheal Disease Research
- Erciyes University
- University of Sao Paulo
- Mutual Pharmaceutical
- Dutch Cancer Society
- MonitorCRO
- General Electric
- Tysana Pte Ltd
- Simbec-Orion
- Prokarium Ltd
Organization Involved with Other Experimental Indications (23)
- Uniformed Services University of the Health Sciences
- United States Navy
- World Health Organization
- University of Arizona
- Brock University
- Ciusss de L'Est de l'Île de Montréal
- Emory University
- Federal University of Minas Gerais
- Hospital Juarez de Mexico
- Ifakara Health Institute
- Makerere University
- Postgraduate Institute of Medical Education and Research
- Queen Sirikit National Institute of Child Health
- University of Palermo
- Dalhousie University
- Suez Canal University
- University of California, Berkeley
- University of Copenhagen
- Icahn School of Medicine at Mount Sinai
- University of Freiburg
- Landstahl Regional Medical Center
- Technion University
- New York Presbyterian Hospital